Esaprazole
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171939This classification denotes an anti-ulcer agent with the molecular formula C12H23N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38QSU0IB5L, chemically known as 1-piperazineacetamide, n-cyclohexyl- but generally known as esaprazole, which bears US NIH Compound Identifier 68835. European Medicines Agency schedules Esaprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06607MIG. The term ESAPRAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). ESAPRAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule esaprazole under HS 29335995 and SITC 51576. As of Q4 2014, ESAPRAZOLE remains the US FDA Preferred Term for this commodity. Esaprazole bears US NLM identifiers UMLS ID C0059583 and NCI Concept Code C65535. SMILES: O=C(NC1CCCCC1)CN1CCNCC1.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.